Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
27.0%
% of ARKG's 38 holdings also in IDNA
23.8%
% of IDNA's 46 holdings also in ARKG
Overlap by Weight
Sector Drift (ARKG minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in ARKG |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
CRISPR THERAPEUTICS AG | 6.7% | 4.6% | 4.6% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | 4.3% | 4.1% | 4.1% |
|
BEAM THERAPEUTICS, INC. | 4.1% | 4.2% | 4.1% |
|
TWIST BIOSCIENCE CORP. | 4.0% | 4.1% | 4.0% |
|
INTELLIA THERAPEUTICS, INC. | 3.9% | 2.2% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
ARKG Overweight Relative to IDNA
|
EXACT SCIENCES CORP | 9.5% |
|
PACIFIC BIOSCIENCES OF CALIF | 5.8% |
|
IONIS PHARMACEUTICALS, INC. | 5.0% |
|
SCHRODINGER, INC. | 5.0% |
|
TELADOC INC | 4.0% |
|
CAREDX, INC. | 3.7% |
|
RECURSION PHARMACEUTICALS, INC CLASS | 3.3% |
|
VERACYTE INC | 3.2% |
|
UIPATH INC CLASS A | 3.0% |
|
ACCOLADE, INC. | 2.9% |
ARKG Underweight Relative to IDNA
|
BLUEPRINT MEDICINES CORP. | -5.6% |
|
EXELIXIS INC | -5.4% |
 |
BIONTECH SE SPONSORED ADR | -4.4% |
 |
SANOFI-AVENTIS | -4.4% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.2% |
|
REGENERON PHARMACEUTICALS | -4.0% |
 |
ROCHE HOLDING LTD | -4.0% |
 |
BEIGENE, LTD. | -3.9% |
 |
GENMAB A/S | -3.9% |
|
SPRINGWORKS THERAPEUTICS, INC. | -3.1% |